AndHealth, a Columbus-based digital health company helping reverse chronic diseases, announced its expansion into downtown Columbus, bringing 65 new jobs to the Columbus Region. The company is planning to hire additional software developers and data scientists, healthcare professionals, physicians and providers and other health experts.
The AndHealth office space will move to 2 Miranova Place in downtown Columbus, a 12-story tower. The new space will allow AndHealth to more than triple its existing employee count while providing room for expansion. AndHealth operates the world’s first-ever Virtual Center of Excellence (VCOE) for migraine reversal and will soon launch a second VCOE for autoimmune diseases, including rheumatoid arthritis, psoriasis, ulcerative colitis and Crohn’s disease. The company works with employers and benefits brokers who offer its healthcare service to support employees in getting their lives back from chronic disease while unlocking productivity and cost savings. It uses a specialty healthcare approach delivered continuously and virtually to help patients participate in their own health by addressing the root cause drivers of their disease.
“We are excited to continue our growth in Columbus,” said Matt Scantland, founder and CEO of AndHealth. “Whether from the employers and patients we serve here, the amazing talent base, or the city and state government, the support from the community has been incredible. This is an ideal place to build a mission-driven company.”
AndHealth is poised to become a new standard of care for employer-sponsored health. Current employee patients and direct out-of-pocket patients who completed the AndHealth Reversal phase report a 76% average reduction in migraine days. After only 30 days in the program, employers are regaining, on average, 23 hours each month per employee in productivity previously lost due to this addressable condition. The company’s responsive and convenient virtual approach has earned it an NPS score of 86, and a leading set of employer and broker partners.
Built for growth, the company is led by an experienced management team of healthcare and technology innovators, including Founder and CEO Matt Scantland, who was the co-founder and CEO of one of the first digital health unicorns, CoverMyMeds. AndHealth gained the backing of leading health technology investor Francisco Partners, and the American Medical Association’s innovation arm, Health 2047 Capital Partners, in a $57 million funding round that was one of the largest first financings for digital health companies.
“AndHealth’s commitment to wellness and community reflects the values of our downtown community, and we’re excited to continue this partnership as the company expands its workforce,” said Andrew J. Ginther, Mayor of Columbus. "Matt Scantland is a proven leader and entrepreneur, and AndHealth will continue to contribute to the industry-leading healthcare advancements happening here. We’re proud to retain and grow this local expertise in our community.”
AndHealth joins the roster of innovative healthcare companies making the Columbus Region home. From medical breakthroughs to cutting-edge technology, the Region has one of the most dynamic healthcare and life science industries in the country. In the past five years, the Columbus Region has granted over 8,700 degrees in biology, biomedical science, chemistry and pharmacy, and The Ohio State University ranks among the top colleges nationally in Biological and Biomedical Science and Engineering – all contributing to a highly-educated and trained talent pool. The City of Columbus is located in Franklin County, which is home to an estimated 1,323,807 residents.
“AndHealth’s new space in downtown Columbus will bring 65 new, high-paying jobs and allow this innovative healthcare company to continue its growth in Central Ohio,” said J.P. Nauseef, president and CEO of JobsOhio. “As AndHealth continues its rise in Ohio, it is also providing healthcare solutions that benefit patients nationwide.”
JobsOhio plans to provide assistance for the project, which will be made public after a final agreement is executed.